Vikash Oza, MD

Articles by Vikash Oza, MD

Take-Home Points

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

September 9th 2022

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.

Case 3 Continued: How to Have Conversation About Risk of Biologics and Length of Therapy

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

September 9th 2022

Atopic dermatitis specialists discuss how to have a conversation with parents about risks of biologics and how to answer questions about length of therapy.

Case 3 Continued: Impressions

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

September 9th 2022

Expert pediatric dermatologists provide impressions on the case of a 12-year-old girl with atopic dermatitis.

Case 3: 12-Year-Old-Female With Atopic Dermatitis

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

September 9th 2022

Joshua Zeichner, MD, reviews the case of a 12-year-old girl with atopic dermatitis.

Case 2 Continued: Importance of Combination Therapy and Shared Decision Making

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

September 1st 2022

Expert pediatric dermatologists discuss the importance of combination therapy and shared decision-making when treating pediatric patients with atopic dermatitis.

Case 2 Continued: Barriers to Treatment Adherence

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

September 1st 2022

Brittany Craiglow, MD, and Joshua Zeichner, MD, discuss treatment adherence in pediatric patients with atopic dermatitis.

Case 2 Continued: Impressions and Recommendations

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

September 1st 2022

Vikash Oza, MD, provides clinical insight for Case 2, a 7-year-old female patient with atopic dermatitis.

Case 2 Continued: Addressing Injectable Medications in Children

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

September 1st 2022

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; and Vikash Oza, MD, address techniques for injectables when treating pediatric patients with atopic dermatitis.

Case 2: 7-Year-Old Female With Atopic Dermatitis

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 31st 2022

Dr Joshua Zeichner reviews the case of a 7-year-old female patient with atopic dermatitis.

Case 1 Continued: Treatments Beyond Topical Agents and the Use of Dupixent

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 31st 2022

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, discuss treatments beyond topical agents and the use of dupilumab in pediatric patients with atopic dermatitis.

Case 1 Continued: Clinical Impressions

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 31st 2022

Expert pediatric dermatologists Drs Elizabeth Swanson, Joshua Zeichner, and Raj Chovatiya share impressions from patient case No. 1.

Case 1: 2-Year-Old Male With Atopic Dermatitis

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 31st 2022

Dr Joshua Zeichner reviews the case of a 2-year-old patient with atopic dermatitis.

Pharmacological Options for the Treatment of Pediatric Atopic Dermatitis

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 11th 2022

Experts treating pediatric atopic dermatitis discuss the pharmacological options for the treatment of pediatric atopic dermatitis.

Burden of Atopic Dermatitis in Pediatric Patients

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 11th 2022

Expert pediatric dermatologists Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the burden of pediatric atopic dermatitis.

Presentation and Diagnosis of Atopic Dermatitis in Pediatrics

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 11th 2022

Brittany Craiglow, MD; Raj Chovatiya, MD, PhD; and Joshua Zeichner, MD, discuss the presentation of pediatric patients with atopic dermatitis and how to properly assess and diagnose pediatric patients’ atopic dermatitis.

Psychological Impact of Atopic Dermatitis in Pediatric Patients

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 11th 2022

Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the psychological factors impacting pediatric patients’ atopic dermatitis.

Mechanism of Action for Agents Used to Treat Pediatric Atopic Dermatitis

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 11th 2022

Joshua Zeichner, MD, and Raj Chovatiya, MD, PhD, dive deep into the pathogenesis of atopic dermatitis and discuss how agents treating atopic dermatitis work.

Characteristics of Type 2 Inflammation and the Impact of Itch

ByJoshua Zeichner, MD,Brittany Craiglow, MD,Elizabeth Swanson, MD,Vikash Oza, MD,Raj Chovatiya, MD, PhD, MSCI

August 11th 2022

Joshua Zeichner, MD, and Vikash Oza, MD, discuss characteristics of type 2 inflammation and the impact of itching on pediatric patients with atopic dermatitis.